Skip to content
Trial Eligibility
Menu

Using Nicotine to Reverse Age-related Auditory Processing Deficits

NCT04971954

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The present study will evaluate the effects of both aging and nicotine on psychophysical tasks and electrophysiological measures. Nicotine will be administered to study participants in the form of gum that is available as an over-the-counter medication. The hypothesis is that nicotine will reverse the detrimental effects of aging on auditory processing. The proposed experiments will characterize the effects of nicotine and may eventually lead to improved treatments of hearing loss in a variety of patient populations and in healthy aging.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Auditory Perceptual Impairment
  • Aging

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 85 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, Irvine
Last updated on ClinicalTrials.gov
August 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Hearing and Speech Lab · Irvine, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.